AcquisitionOther
Novartis AG acquired Avidity Biosciences Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Novartis AG -> Avidity Biosciences Inc. · approximately USD 12.0 billion
Acquire Avidity's neuroscience programs and differentiated RNA-targeting delivery platform.
Open source record (SEC) ↗